These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis]. Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669 [TBL] [Abstract][Full Text] [Related]
8. Inflammations mediators and circulating levels of matrix metalloproteinases: Biomarkers of diabetes in Tunisians metabolic syndrome patients. Zayani Y; El Golli N; Zidi W; Guizani I; Boussairi S; Aloui S; Ayadi I; Ftouhi B; Feki M; Ben Romdhane N; Ben Sliman H; Allal-Elasmi M; Kaabachi N Cytokine; 2016 Oct; 86():47-52. PubMed ID: 27455450 [TBL] [Abstract][Full Text] [Related]
9. Combined Cathepsin S and hs-CRP predicting inflammation of abdominal aortic aneurysm. Qin Y; Yang Y; Liu R; Cao X; Liu O; Liu J; Wang M; Yang Y; Chen Z; Zhang H; Du J Clin Biochem; 2013 Aug; 46(12):1026-1029. PubMed ID: 23742758 [TBL] [Abstract][Full Text] [Related]
10. Measurement of MMP-9 and -12 degraded elastin (ELM) provides unique information on lung tissue degradation. Skjøt-Arkil H; Clausen RE; Nguyen QH; Wang Y; Zheng Q; Martinez FJ; Hogaboam CM; Han M; Klickstein LB; Larsen MR; Nawrocki A; Leeming DJ; Karsdal MA BMC Pulm Med; 2012 Jul; 12():34. PubMed ID: 22818364 [TBL] [Abstract][Full Text] [Related]
11. Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis. Mattey DL; Packham JC; Nixon NB; Coates L; Creamer P; Hailwood S; Taylor GJ; Bhalla AK Arthritis Res Ther; 2012 May; 14(3):R127. PubMed ID: 22640827 [TBL] [Abstract][Full Text] [Related]
13. C-reactive protein polymorphisms influence serum CRP-levels independent of disease activity in ankylosing spondylitis. Claushuis TA; de Vries MK; van der Weijden MA; Visman IM; Nurmohamed MT; Twisk JW; Van der Horst-Bruinsma IE; Crusius JB Clin Exp Rheumatol; 2015; 33(2):159-65. PubMed ID: 25603416 [TBL] [Abstract][Full Text] [Related]
14. Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study. Bay-Jensen AC; Leeming DJ; Kleyer A; Veidal SS; Schett G; Karsdal MA Rheumatol Int; 2012 Nov; 32(11):3565-72. PubMed ID: 22086471 [TBL] [Abstract][Full Text] [Related]
15. CRP and a biomarker of type I collagen degradation, C1M, can differentiate anti-inflammatory treatment response in ankylosing spondylitis. Siebuhr AS; Bay-Jensen AC; Karsdal MA; Lories RJ; de Vlam K Biomark Med; 2016; 10(2):197-208. PubMed ID: 26764293 [TBL] [Abstract][Full Text] [Related]
16. Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort. Saberi Hosnijeh F; Siebuhr AS; Uitterlinden AG; Oei EH; Hofman A; Karsdal MA; Bierma-Zeinstra SM; Bay-Jensen AC; van Meurs JB Arthritis Res Ther; 2016 Apr; 18():81. PubMed ID: 27039382 [TBL] [Abstract][Full Text] [Related]
17. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover. Pedersen SJ; Sørensen IJ; Lambert RG; Hermann KG; Garnero P; Johansen JS; Madsen OR; Hansen A; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen KH; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Østergaard M Arthritis Rheum; 2011 Dec; 63(12):3789-800. PubMed ID: 22127697 [TBL] [Abstract][Full Text] [Related]
18. Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Maksymowych WP; Landewé R; Conner-Spady B; Dougados M; Mielants H; van der Tempel H; Poole AR; Wang N; van der Heijde D Arthritis Rheum; 2007 Jun; 56(6):1846-53. PubMed ID: 17530713 [TBL] [Abstract][Full Text] [Related]
19. Development of a Novel Enzyme-Linked Immunosorbent Assay Targeting a Neo-Epitope Generated by Cathepsin-Mediated Turnover of Type III Collagen and Its Application in Chronic Obstructive Pulmonary Disease. Rasmussen DG; Sand JM; Karsdal MA; Genovese F PLoS One; 2017; 12(1):e0170023. PubMed ID: 28076408 [TBL] [Abstract][Full Text] [Related]
20. Cartilage biomarkers in ankylosing spondylitis: relationship to clinical variables and treatment response. Kim TH; Stone M; Payne U; Zhang X; Ionescu M; Lobanok T; King L; Poole AR; Inman RD Arthritis Rheum; 2005 Mar; 52(3):885-91. PubMed ID: 15751093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]